
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer
Zhenkun Wang, Ensong Guo, Bin Yang, et al.
Gynecologic Oncology (2021) Vol. 163, Iss. 2, pp. 358-363
Closed Access | Times Cited: 80
Zhenkun Wang, Ensong Guo, Bin Yang, et al.
Gynecologic Oncology (2021) Vol. 163, Iss. 2, pp. 358-363
Closed Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Burden of osteoarthritis in China, 1990–2019: findings from the Global Burden of Disease Study 2019
Hongying Li, Weisi Kong, Yan Liang, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1189-1197
Open Access | Times Cited: 17
Hongying Li, Weisi Kong, Yan Liang, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1189-1197
Open Access | Times Cited: 17
Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level
Ying Wang, Zhi Wang, Zihui Zhang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 25
Ying Wang, Zhi Wang, Zihui Zhang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 25
Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Maria-Bianca Anca-Stanciu, Andrei Manu, Maria Olincă, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1385-1385
Open Access | Times Cited: 1
Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years
Jianyang Feng, Lijiang Xu, Yangping Chen, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Jianyang Feng, Lijiang Xu, Yangping Chen, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer
Yingtao Lin, Chang Wang, Xiaoyan He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Yingtao Lin, Chang Wang, Xiaoyan He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation
Ting‐Ting Gong, Fang-Hua Liu, Qian Xiao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Ting‐Ting Gong, Fang-Hua Liu, Qian Xiao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Analysis of the global burden of cervical cancer in young women aged 15–44 years old
Min Zhang, Jiayi Chen, Meimei Cui, et al.
European Journal of Public Health (2024) Vol. 34, Iss. 4, pp. 839-846
Open Access | Times Cited: 6
Min Zhang, Jiayi Chen, Meimei Cui, et al.
European Journal of Public Health (2024) Vol. 34, Iss. 4, pp. 839-846
Open Access | Times Cited: 6
DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
Mengying Jiang, Yizuo Song, Hejing Liu, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 546-546
Open Access | Times Cited: 15
Mengying Jiang, Yizuo Song, Hejing Liu, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 546-546
Open Access | Times Cited: 15
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer
Shuai Zong, Ping-ping Xu, Yinhai Xu, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Shuai Zong, Ping-ping Xu, Yinhai Xu, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
Minmin Zhao, Shanhu Qiu, Xin Wu, et al.
Targeted Oncology (2023) Vol. 18, Iss. 6, pp. 869-883
Open Access | Times Cited: 12
Minmin Zhao, Shanhu Qiu, Xin Wu, et al.
Targeted Oncology (2023) Vol. 18, Iss. 6, pp. 869-883
Open Access | Times Cited: 12
Temporal trends and projections of gynecological cancers in China, 2007–2030
Rufei Duan, Hongping Zhang, Jing Yu, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Rufei Duan, Hongping Zhang, Jing Yu, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Testing for viral DNA integration among HPV‐positive women to detect cervical precancer: An observational cohort study
Ting Hu, Kexin Li, Liang He, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2023) Vol. 131, Iss. 3, pp. 309-318
Open Access | Times Cited: 11
Ting Hu, Kexin Li, Liang He, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2023) Vol. 131, Iss. 3, pp. 309-318
Open Access | Times Cited: 11
Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway
Hao Wang, Yinhai Xu, Yi Guo
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Hao Wang, Yinhai Xu, Yi Guo
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Dyadic coping, resilience, and quality of life in young and middle-aged couples after gynecologic cancer: An actor-partner interdependence mediation model
Xinru Deng, Qianru Liu, Li Geng, et al.
European Journal of Oncology Nursing (2024) Vol. 70, pp. 102601-102601
Closed Access | Times Cited: 4
Xinru Deng, Qianru Liu, Li Geng, et al.
European Journal of Oncology Nursing (2024) Vol. 70, pp. 102601-102601
Closed Access | Times Cited: 4
Mitochondrial‐Derived Peptide MOTS‐c Suppresses Ovarian Cancer Progression by Attenuating USP7‐Mediated LARS1 Deubiquitination
Yadong Yin, Yujie Li, Boyi Ma, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Yadong Yin, Yujie Li, Boyi Ma, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Trends in national and ethnic burden of ovarian cancer mortality in South Africa (1999–2018): a population based, age-period-cohort and join point regression analyses
Gbenga Olorunfemi, Elena Libhaber, Oliver Ezechi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Gbenga Olorunfemi, Elena Libhaber, Oliver Ezechi, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Analysis of the disease burden of malignancies in the female reproductive system in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis
Jiayi Li, Xinyu Zhao, Xiaoman Li, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e081511-e081511
Open Access
Jiayi Li, Xinyu Zhao, Xiaoman Li, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e081511-e081511
Open Access
Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis
Yiran E. Liu, Wenqi Shi, Sumaira Mubarik, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Yiran E. Liu, Wenqi Shi, Sumaira Mubarik, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021
Wenhui Ren, Xiangyu Guo, Zheng Liu, et al.
Cancer (2025) Vol. 131, Iss. 2
Open Access
Wenhui Ren, Xiangyu Guo, Zheng Liu, et al.
Cancer (2025) Vol. 131, Iss. 2
Open Access
Trends and ethnic disparity in endometrial cancer mortality in South Africa (1999–2018): A population-based Age-period-cohort and Join point regression analyses
Gbenga Olorunfemi, Elena Libhaber, Oliver Ezechi, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313487-e0313487
Open Access
Gbenga Olorunfemi, Elena Libhaber, Oliver Ezechi, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313487-e0313487
Open Access
Acupuncture treatment of postoperative urinary retention in cervical cancer: Systematic evaluation and meta-analysis
Hui Xu, Yujun He, Fu-Rui Miao, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41520-e41520
Open Access
Hui Xu, Yujun He, Fu-Rui Miao, et al.
Medicine (2025) Vol. 104, Iss. 8, pp. e41520-e41520
Open Access
Time trends in disability-adjusted life years for cataracts attributable to indoor air pollution across 17 low- and middle-income countries
Yue Yang, Justino Jose Capapelo, Yanrong Wang, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41914-e41914
Open Access
Yue Yang, Justino Jose Capapelo, Yanrong Wang, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41914-e41914
Open Access
miR-126-5p suppresses HeLa and Ishikawa cell proliferation and migration via the RICTOR/AKT pathway
Xuan Zhang, Yanjing Yang, Yaqin Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Xuan Zhang, Yanjing Yang, Yaqin Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Regional differences in the disease burden and attributable risk factors of female cancers
Chunhui Li, Ke Peng
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Chunhui Li, Ke Peng
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Global and China burden of hormone-related cancers and risk factors, 1990–2021: results from the Global Burden of Disease Study 2021
Xiaoyu Hu, Jingjing Lv, Chang Qin, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Xiaoyu Hu, Jingjing Lv, Chang Qin, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access